Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Spironolactone Tablets for the Treatment of Children With Gene Mutations Related to NCOR

NCT06678685 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06678685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06678685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Spironolactone Tablets for the Treatment of Children With Gene Mutations Related to NCOR
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 30, 2024
Completion date
December 30, 2027
Enrollment
2 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, ncor gene mutations, spironolactone